Compare PRCT & OXLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRCT | OXLC |
|---|---|---|
| Founded | 2009 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 982.8M |
| IPO Year | 2021 | 2010 |
| Metric | PRCT | OXLC |
|---|---|---|
| Price | $18.20 | $8.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 1 |
| Target Price | ★ $22.42 | $6.00 |
| AVG Volume (30 Days) | ★ 1.3M | 1.0M |
| Earning Date | 11-03-2026 | 11-01-2023 |
| Dividend Yield | N/A | ★ 18.86% |
| EPS Growth | ★ 1.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $308,054,000.00 | N/A |
| Revenue This Year | $28.36 | $136.15 |
| Revenue Next Year | $20.55 | $5.51 |
| P/E Ratio | ★ N/A | $7.72 |
| Revenue Growth | ★ 37.22 | N/A |
| 52 Week Low | $16.67 | $8.01 |
| 52 Week High | $38.11 | $16.82 |
| Indicator | PRCT | OXLC |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 29.81 |
| Support Level | $16.84 | $8.11 |
| Resistance Level | $22.88 | $9.10 |
| Average True Range (ATR) | 0.86 | 0.19 |
| MACD | 0.09 | -0.05 |
| Stochastic Oscillator | 59.55 | 21.48 |
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.